Metraipolis › archive › dc_c708f6e1abc2
PKM2-Mediated Glycolytic Reprogramming in Thyroid Cancer: Mechanistic Insights and Therapeutic Potential — Europe PMC PMID:42280115
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42280115
- DOI
- 10.3390/molecules31111811
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T08:03:38.833Z
- SHA-256 of the archived text
f945153f448b4e1b129b1a481e00c1b804af75df5cd9aa1afc8a83ecc2a8aa42- Stable URL of this page
https://metraipolis.com/documento/dc_c708f6e1abc2
How to cite
PKM2-Mediated Glycolytic Reprogramming in Thyroid Cancer: Mechanistic Insights and Therapeutic Potential — Europe PMC PMID:42280115 — Europe PMC (en), https://europepmc.org/article/MED/42280115 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c708f6e1abc2 (Metraipolis archive dc_c708f6e1abc2, sha256 f945153f448b4e1b129b1a481e00c1b804af75df5cd9aa1afc8a83ecc2a8aa42)
BibTeX
@misc{dcc708f6e1abc2,
title = {PKM2-Mediated Glycolytic Reprogramming in Thyroid Cancer: Mechanistic Insights and Therapeutic Potential — Europe PMC PMID:42280115},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42280115},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c708f6e1abc2; sha256 f945153f448b4e1b129b1a481e00c1b804af75df5cd9aa1afc8a83ecc2a8aa42},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42280115. Agents can read the archived copy with the MCP tool read_document.